Based in Montréal, CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S.
CTI Life Sciences currently manage $245 million of assets.
Azure is a venture capital firm with over $750 million under management. They invest in post-seed and early stage companies at an inflection point of growth.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.